During the recent session, Medical Properties Trust Inc (NYSE:MPW)’s traded shares were 1.94 million, with the beta value of the company hitting 1.30. At the last check today, the stock’s price was $4.73, reflecting an intraday gain of 0.42% or $0.02. The 52-week high for the MPW share is $10.74, that puts it down -127.06 from that peak though still a striking 38.27% gain since the share price plummeted to a 52-week low of $2.92. The company’s market capitalization is $2.84B, and the average intraday trading volume over the past 10 days was 11.56 million shares, and the average trade volume was 15.56 million shares over the past three months.

Medical Properties Trust Inc (MPW) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.50. MPW has a Sell rating from 1 analyst(s) out of 9 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.06.

Medical Properties Trust Inc (NYSE:MPW) trade information

Medical Properties Trust Inc (MPW) registered a 0.42% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.42% in intraday trading to $4.73, hitting a weekly high. The stock’s 5-day price performance is 4.65%, and it has moved by -1.66% in 30 days. Based on these gigs, the overall price performance for the year is -54.65%. The short interest in Medical Properties Trust Inc (NYSE:MPW) is 195.63 million shares and it means that shorts have 16.39 day(s) to cover.

The extremes of the forecast give a target low and a target high price of $4 and $27 respectively. As a result, MPW is trading at a discount of -470.82% off the target high and 15.43% off the low.

Medical Properties Trust Inc (MPW) estimates and forecasts

Statistics show that Medical Properties Trust Inc has underperformed its competitors in share price, compared to the industry in which it operates. Medical Properties Trust Inc (MPW) shares have gone up 54.07% during the last six months, with a year-to-date growth rate less than the industry average at -44.65% against -3.10. In the rating firms’ projections, revenue will decrease -25.10% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 249.22M as predicted by 8 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to 237.74M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 337.39M and 306.58M respectively. In this case, analysts expect current quarter sales to shrink by -26.10% and then drop by -22.50% in the coming quarter.

While earnings are projected to return 27.72% in 2024.

MPW Dividends

Medical Properties Trust Inc is due to release its next quarterly earnings in August. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Medical Properties Trust Inc is 0.60, with the dividend yield indicating at 12.68 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 9.01%.

Medical Properties Trust Inc (NYSE:MPW)’s Major holders

The next largest institutional holding, with 93.06 million shares, is of VANGUARD GROUP INC’s that is approximately 15.536% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $437.37 million.